ANDA 213247, held by Twi Pharms. Metformin Hydrochloride.
As of Nov 16, 2026, ANDA 213247 (Metformin Hydrochloride), held by Twi Pharms, was first approved by FDA on Sep 29, 2021, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 29, 2021 | Original application | Approved | None posted |
| Metformin Hydrochloride500MG · tablet, extended release;oral | Metformin Hydrochloride | Discontinued |
| Metformin Hydrochloride1GM · tablet, extended release;oral | Metformin Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters